M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Slides:

Advertisements

Similar presentations

Volume 68, Pages S24-S28 (July 2005)

Advertisements

Volume 69, Issue 1, Pages (January 2006)

Beta blockers in the management of chronic kidney disease

Volume 67, Pages S1-S7 (June 2005)

Volume 73, Issue 1, Pages 3-5 (January 2008)

Anemia management in chronic kidney disease

Volume 79, Issue 9, Pages (May 2011)

FGF23 or PTH: which comes first in CKD ?

Pieter Evenepoel, Myles Wolf Kidney International

Vitamin D deficiency and heart disease

FGF23–parathyroid interaction: implications in chronic kidney disease

Reassessment of the care of the patient with chronic kidney disease

Progression of renal failure and hypertensive nephrosclerosis

John P. Middleton, Patrick H. Pun Kidney International

Inflammation and wasting in chronic kidney disease: Partners in crime

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Vitamin E treatment of experimental glomerular disease in rats

Chapter 3: Management of progression and complications of CKD

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Volume 76, Pages S50-S99 (August 2009)

Volume 70, Pages S21-S25 (December 2006)

Volume 72, Issue 6, Pages (September 2007)

Volume 66, Pages S13-S17 (September 2004)

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

A new era in phosphate binder therapy: What are the options?

Volume 72, Issue 5, Pages (September 2007)

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Volume 79, Pages S20-S23 (April 2011)

The need for reliable serum parathyroid hormone measurements

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

The epidemiology of chronic kidney disease

Use of vitamin D in chronic kidney disease patients

Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.

Florian Lang, Michael Föller Kidney International

Volume 67, Pages S33-S36 (June 2005)

Junichiro J. Kazama, Masafumi Fukagawa Kidney International

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 73, Pages S5-S17 (April 2008)

Volume 71, Issue 6, Pages (March 2007)

The calcium–phosphorus in guidelines for CKD-MBD

Volume 69, Issue 3, Pages (February 2006)

Vitamin D receptor: A highly versatile nuclear receptor

Volume 70, Issue 12, Pages (December 2006)

Volume 68, Pages S24-S28 (July 2005)

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

The third World Kidney Day: Looking back and thinking forward

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Volume 87, Issue 3, Pages (March 2015)

Methods for guideline development

AGEs in foods: Do they play a role in uremia?

Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson Kidney International

Volume 75, Issue 9, Pages (May 2009)

Fibroblast growth factor 23: the making of a hormone

Organ transplantation goes to the movies

Volume 72, Issue 2, Pages (July 2007)

Pablo A. Ureña Torres, Marc De Broe Kidney International

Volume 55, Pages S3-S16 (June 1999)

Volume 69, Issue 1, Pages (January 2006)

Effect of lipid-lowering strategies on tubular cell biology

Is it the low-protein diet or simply the salt restriction?

Volume 70, Issue 3, Pages (August 2006)

Volume 71, Issue 9, Pages (May 2007)

Volume 70, Issue 5, Pages (September 2006)

The ins and outs of phosphate homeostasis

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Volume 86, Issue 2, Pages (August 2014)

Presentation transcript:

Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International Volume 70, Pages S3-S7 (July 2006) DOI: 10.1038/sj.ki.5001594 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Progression of parathyroid hyperplasia in CKD. Kidney International 2006 70, S3-S7DOI: (10.1038/sj.ki.5001594) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Role of FGF23 in the development of severe hyperparathyroidism. PTH, high phosphorus level, and vitamin D treatment increase FGF23 production in the bone. Very high level of FGF23 may directly stimulate parathyroid cell proliferation. Kidney International 2006 70, S3-S7DOI: (10.1038/sj.ki.5001594) Copyright © 2006 International Society of Nephrology Terms and Conditions